Forte Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Forte Biosciences has a total shareholder equity of $17.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.1M and $9.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$24.50m |
| Equity | US$16.96m |
| Total liabilities | US$9.12m |
| Total assets | US$26.08m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 37T's short term assets ($25.7M) exceed its short term liabilities ($9.1M).
Long Term Liabilities: 37T has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 37T is debt free.
Reducing Debt: 37T has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 37T has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 37T has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.9% each year